BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ierardi E, Losurdo G, Fortezza RFL, Principi M, Barone M, Leo AD. Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness. World J Gastroenterol 2019; 25(34): 5097-5104 [PMID: 31558859 DOI: 10.3748/wjg.v25.i34.5097]
URL: https://www.wjgnet.com/1007-9327/full/v25/i34/5097.htm
Number Citing Articles
1
Enzo Ierardi, Giuseppe Losurdo, Alessia Mileti, Rosa Paolillo, Floriana Giorgio, Mariabeatrice Principi, Alfredo Di Leo. The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic ScienceAntibiotics 2020; 9(6): 293 doi: 10.3390/antibiotics9060293
2
Seokin Kang, Yuri Kim, Ji Yong Ahn, Hwoon-Yong Jung, Nayoung Kim, Hee Kyong Na, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical SettingAntibiotics 2021; 10(2): 214 doi: 10.3390/antibiotics10020214
3
Angela B. Muñoz, Johanna Stepanian, Alba Alicia Trespalacios, Filipa F. Vale. Bacteriophages of Helicobacter pyloriFrontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.549084
4
Muhammad Miftahussurur, Boby Pratama Putra, Yoshio Yamaoka. The Potential Benefits of Vonoprazan as Helicobacter pylori Infection TherapyPharmaceuticals 2020; 13(10): 276 doi: 10.3390/ph13100276
5
Anthony O'Connor, Takahisa Furuta, Javier P. Gisbert, Colm O'Morain. Review – Treatment of Helicobacter pylori infection 2020 Helicobacter 2020; 25(S1) doi: 10.1111/hel.12743
6
Diego Reyes, Javier Ortiz, Eduardo Fuentes-López, Sigall Budnik, Vicente Gándara, Andrea Gallardo, María Francisca Seydewitz, Roberto Candia, José Ignacio Vargas, María Paz Rollan, Javiera Godoy, Antonio Rollan, Rodrigo Mansilla, Alex Arenas, Javier Chahuán, Alberto Espino, Margarita Pizarro, Arnoldo Riquelme. Terapias cuádruples son superiores a terapia triple estándar en primera línea de erradicación de Helicobacter pylori en ChileGastroenterología y Hepatología 2022; 45(7): 515 doi: 10.1016/j.gastrohep.2021.11.010
7
Zhaoshi Bai, Nianyang Ding, Jianjuan Ge, Yue Wang, Lei Wang, Nan Wu, Qing Wei, Silu Xu, Xiaolin Liu, Guoren Zhou. Esomeprazole overcomes paclitaxel‐resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cellsCell Biology International 2021; 45(1): 177 doi: 10.1002/cbin.11481
8
Dicky Pranantyo, Kaixi Zhang, Zhangyong Si, Zheng Hou, Mary B. Chan-Park. Smart Multifunctional Polymer Systems as Alternatives or Supplements of Antibiotics To Overcome Bacterial ResistanceBiomacromolecules 2022; 23(5): 1873 doi: 10.1021/acs.biomac.1c01614
9
Giuseppe Losurdo, Ilaria Lacavalla, Francesco Russo, Giuseppe Riezzo, Irene Vita Brescia, Maria Rendina, Enzo Ierardi, Alfredo Di Leo. Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern ItalyAntibiotics 2022; 11(1): 78 doi: 10.3390/antibiotics11010078
10
Pedro Cortés, Alfred D. Nelson, Yan Bi, Fernando F. Stancampiano, Loren P. Murray, George G.A. Pujalte, Victoria Gomez, Dana M. Harris. Treatment Approach of Refractory Helicobacter pylori Infection: A Comprehensive ReviewJournal of Primary Care & Community Health 2021; 12: 215013272110140 doi: 10.1177/21501327211014087
11
Paulius Jonaitis, Juozas Kupcinskas, Olga P. Nyssen, Ignasi Puig, Javier P. Gisbert, Laimas Jonaitis. Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013–2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg)Medicina 2021; 57(7): 642 doi: 10.3390/medicina57070642
12
Pranjal Kumar Singh, T.S. Easwari. Emerging Trends and their Impacts on Peptic Ulcer Diseases: Treatments and TechniquesCurrent Drug Therapy 2022; 17(1): 2 doi: 10.2174/1574885517666220307115813
13
Diego Reyes, Javier Ortiz, Eduardo Fuentes-López, Sigall Budnik, Vicente Gándara, Andrea Gallardo, María Francisca Seydewitz, Roberto Candia, José Ignacio Vargas, María Paz Rollan, Javiera Godoy, Antonio Rollan, Rodrigo Mansilla, Alex Arenas, Javier Chahuán, Alberto Espino, Margarita Pizarro, Arnoldo Riquelme. Quadruple therapies are superior to standard triple therapy for Helicobacter pylori first-line eradication in ChileGastroenterología y Hepatología (English Edition) 2022; 45(7): 515 doi: 10.1016/j.gastre.2022.07.004
14
Chao Ran Ji, Jing Liu, Yue Yue Li, Chen Qiao, Jun Yan Qu, Jun Nan Hu, Min Juan Lin, Rui Ji, Li Xiang Li, Xiu Li Zuo, Yan Qing Li. Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial Journal of Digestive Diseases 2020; 21(10): 549 doi: 10.1111/1751-2980.12934
15
Qiuyue Huang, Zongming Shi, Hong Cheng, Hui Ye, Xuezhi Zhang. Efficacy and Safety of Modified Dual Therapy as the First-line Regimen for the Treatment of Helicobacter pylori InfectionJournal of Clinical Gastroenterology 2021; 55(10): 856 doi: 10.1097/MCG.0000000000001448
16
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategiesCritical Reviews in Microbiology 2022; 48(3): 376 doi: 10.1080/1040841X.2021.1975643
17
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?Revista de Gastroenterología de México (English Edition) 2022; 87(3): 330 doi: 10.1016/j.rgmxen.2022.06.003
18
Xiaoye Shi, Chunmei Wang, Fanjun Meng, Shaoze Ma, Guangqin Xu, Tingwei Liu, Xiaozhong Guo, Hongyu Li, Xingshun Qi. Impact of insufficient doses of medications on Helicobacter pylori eradication: a retrospective observational studyPostgraduate Medicine 2022; 134(7): 668 doi: 10.1080/00325481.2022.2105094
19
Karolina Kasza, Pratik Gurnani, Kim R. Hardie, Miguel Cámara, Cameron Alexander. Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: A tissue-by-tissue accountAdvanced Drug Delivery Reviews 2021; 178: 113973 doi: 10.1016/j.addr.2021.113973
20
Kiarash Ghazvini, Hossein Kamali, Seyed-Abolfazl Hosseininasab-nodoushan, Masoud Keikha. The CYP2C19 polymorphisms effects on H. pylori cure rate in proton pump inhibitor-based therapeutic regimens: An updated meta-analysisGene Reports 2021; 25: 101340 doi: 10.1016/j.genrep.2021.101340
21
Jin Young Yoon, Min Seob Kwak, Jung Won Jeon, Jae Myung Cha. Pretreatment with Ranitidine Bismuth Citrate May Improve Success Rates of <i>Helicobacter pylori</i> Eradication: A Prospective, Randomized, Controlled and Open-Label StudyThe Tohoku Journal of Experimental Medicine 2021; 255(1): 41 doi: 10.1620/tjem.255.41
22
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine2022; : 51 doi: 10.2174/9789815051780122010005
23
Erick A. Argueta, Steven F. Moss. How We Approach Difficult to Eradicate Helicobacter pyloriGastroenterology 2022; 162(1): 32 doi: 10.1053/j.gastro.2021.10.048
24
Heloisa B. Assalin, Kelly Cristiane Gabriel De Almeida, Dioze Guadagnini, Andrey Santos, Caio J. Teixeira, Silvana Bordin, Guilherme Z. Rocha, Mario J. A. Saad. Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse LiverInternational Journal of Molecular Sciences 2022; 23(22): 13766 doi: 10.3390/ijms232213766
25
Wenwen Gao, Xiang Zhang, Yanhui Yin, Shuwen Yu, Lu Wang. Different dose of new generation proton pump inhibitors for the treatment of Helicobacter pylori infection: A meta-analysisInternational Journal of Immunopathology and Pharmacology 2021; 35: 205873842110303 doi: 10.1177/20587384211030397
26
Ana C. P. Correia, Danielle Straub, Silvia Calpe, Kausilia K. Krishnadath. Novel In Vivo Mouse Cryoablation Model to Explore Unique Therapeutic Approaches for Premalignant Columnar LesionsMethods and Protocols 2021; 4(1): 6 doi: 10.3390/mps4010006
27
XinBo Xu, Cong He, Yin Zhu. Treatment of refractory Helicobacter pylori infection: A new challenge for cliniciansFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.998240
28
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H.pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?Revista de Gastroenterología de México 2022; 87(3): 330 doi: 10.1016/j.rgmx.2022.01.007
29
Hyeonsoo Park, Choon Ok Kim, Mikyung Kim, Yeji Lim, Woo Yul Lee, Sukyong Yoon, Min Soo Park. Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjectsTranslational and Clinical Pharmacology 2020; 28(3): 136 doi: 10.12793/tcp.2020.28.e16